טוען...
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects
Background Recombinant (rec-) coagulation factor VIII concentrates available for hemophilia A (HA) treatment differ in cell line production and structure, which could affect their pharmacodynamics and immunogenicity. Clinical trials showed that previously untreated patients with severe HA present h...
שמור ב:
| הוצא לאור ב: | TH Open |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Georg Thieme Verlag KG
2019
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524925/ https://ncbi.nlm.nih.gov/pubmed/31249992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1688413 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|